Clinical Trials Browser

Completed × OTHER × Genetic Counseling × Clear all

Prostatic Neoplasms

NCT03460483 2025-10-03

OPTEC

Phase NA Completed

1,001 enrolled

GastrointestinalGynecologic

Colorectal Neoplasms, Hereditary Nonpolyposis, Endometrial Neoplasms

NCT04456140 2023-07-24

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

Phase 1 Completed

230 enrolled

BreastCNSGastrointestinalHead & Neck

Brain Neoplasms, Breast Neoplasms, Digestive System Neoplasms, Head and Neck Neoplasms, Neoplasms, Unknown Primary, Urogenital Neoplasms, Central Nervous System Neoplasms

NCT03075540 2019-12-12

Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer

Phase NA Completed

88 enrolled

BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

NCT01850654 2018-06-28

OCCPI

Phase NA Completed

3,470 enrolled

GastrointestinalGynecologic

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Rectal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT01851109 2016-01-28

Prevention of Ovarian Cancer in Women Participating in Mammography

Phase NA Completed

458 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00165152 2012-08-09

Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing

Phase NA Completed

150 enrolled

BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Ovarian Neoplasms

Clinical Trials

Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study

OPTEC

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer

OCCPI

Prevention of Ovarian Cancer in Women Participating in Mammography

Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing